NMTC

NeuroOne Medical Technologies Corp

0.9272

Oct 30 • 3:59 PM ET -0.0426 (-4.39%)

0.9272

Aftermarket • 7:30 PM ET 0.0000 (0.00%)

Healthcare Medical Devices USA Nano NASD

Oct 29, 8:05 AMNeuroOne Medical peer-reviewed study shows strong initial pain relief with OneRF Trigeminal Nerve Ablation System

Peers: CLPT NPCE CBLL MOBI ECOR NXL ITGR MDT AMIX MBOT

| Held by: VTI VXF IWC

Scroll to Statements

Index	-
Market Cap	8.44M
Enterprise Value	6.57M
Income	-7.45M
Sales	9.47M
Book/sh	0.43
Cash/sh	0.23
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	18
IPO	Jun 27, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	0.89
P/B	2.14
P/C	4.12
P/FCF	-
EV/EBITDA	-
EV/Sales	0.69
Quick Ratio	1.70
Current Ratio	2.82
Debt/Eq	0.05
LT Debt/Eq	0.02
Option/Short	Yes / Yes

EPS (ttm)	-0.92
EPS next Y	-0.63
EPS next Q	-0.19
EPS this Y	-32.10%
EPS next Y	11.21%
EPS next 5Y	14.29%
EPS past 3/5Y	47.63% 48.67%
Sales past 3/5Y	78.70% 44.41%
EPS Y/Y TTM	7.34%
Sales Y/Y TTM	-1.67%
EPS Q/Q	-48.62%
Sales Q/Q	16.34%
Earnings	Aug 19
EPS/Sales Surpr.	0.00% 0.46%

Insider Own	20.39%
Insider Trans	1.27%
Inst Own	29.66%
Inst Trans	0.91%
ROA	-87.56%
ROE	-124.66%
ROIC	-193.85%
Gross Margin	55.65%
Oper. Margin	-83.43%
Profit Margin	-78.63%
SMA20	-7.26%
SMA50	-29.92%
SMA200	-71.05%
Trades

Shs Outstand	8.70M
Shs Float	7.25M
Short Float	2.86%
Short Ratio	0.61
Short Interest	0.21M
52W High	6.12 -84.85%
52W Low	0.77 20.12%
Volatility	14.63% 11.22%
ATR (14)	0.12
RSI (14)	39.95
Beta	0.92
Rel Volume	0.10
Avg Volume	342.04K
Volume	33,829

Perf Week	0.86%
Perf Month	-5.88%
Perf Quarter	-45.46%
Perf Half Y	-78.69%
Perf YTD	-79.61%
Perf Year	-80.49%
Perf 3Y	-82.82%
Perf 5Y	-94.52%
Perf 10Y	-90.63%
Recom	1.00
Target Price	7.27
Prev Close	0.97
Price	0.93
Change %	-4.39%

Consensus

Strong Buy

Avg. Price Target

$7.27

Implied Upside

+684.1%

Analysts2incl. previous ratings

Rating Distribution1 Buy · 1 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
May 05, 2025	Initiated	LLadenburg Thalmann	Buy	$1.45	+56.4%
Mar 29, 2022	Downgrade	CCraig Hallum	Buy → Hold	$6 → $2	+115.7%

Oct-29-26 08:00AM	NeuroOne Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF Trigeminal Nerve Ablation System (GlobeNewswire) +12.96%
Oct-27-26 08:00AM	NeuroOne Featured in New York Post on OneRF Patient's Remarkable Journey to Overcome Debilitating Facial Pain (GlobeNewswire) +5.72%
Oct-22-26 08:31AM	NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program (GlobeNewswire) +7.54%
Oct-08-26 04:01PM	NeuroOne Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology (GlobeNewswire)
Oct-05-26 09:17AM	NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order (GlobeNewswire)
09:05AM	Loading…
Aug-27-26 09:05AM	NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform (NewMediaWire)
Aug-17-26 03:03PM	NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Call Highlights: Revenue Grows 16% ... (GuruFocus.com)
Aug-13-26 08:00AM	NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% (NewMediaWire) +20.39%
Aug-11-26 08:30AM	NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification (NewMediaWire)
Aug-03-26 08:30AM	NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time (NewMediaWire)
Jul-30-26 04:05PM	NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform (NewMediaWire)
Jul-28-26 08:30AM	NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians (NewMediaWire) -5.11%
Jul-16-26 08:30AM	NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial (NewMediaWire) -5.58%
Jun-29-26 08:30AM	NeuroOne(R) Added to Russell Microcap(R) Index (NewMediaWire)
Jun-25-26 05:00PM	NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (NewMediaWire)
08:30AM	Loading…
Jun-16-26 08:30AM	NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index (NewMediaWire)
Jun-08-26 08:30AM	NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time (NewMediaWire)
May-28-26 08:30AM	NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026 (NewMediaWire)
May-22-26 04:30PM	NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 (NewMediaWire) -5.38%
May-12-26 07:02PM	NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Call Highlights: Strong Product ... (GuruFocus.com)
08:00AM	NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update (NewMediaWire)
May-11-26 09:23AM	NeuroOne Medical Technologies Corp (NMTC) Q2 2026 Earnings Report Preview: What to Look For (GuruFocus.com) -9.03%
May-04-26 08:30AM	NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement (NewMediaWire)
Apr-30-26 08:30AM	NeuroOne(R) Announces Chief Financial Officer Succession Plan (NewMediaWire)
Apr-28-26 08:30AM	NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time (NewMediaWire)
Apr-15-26 08:30AM	NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota (NewMediaWire)
Apr-14-26 08:30AM	NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance (NewMediaWire)
Apr-02-26 05:18PM	NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (NewMediaWire)
Mar-26-26 08:30AM	NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System (NewMediaWire)
Mar-17-26 08:30AM	NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology (NewMediaWire)
04:01PM	Loading…
Mar-11-26 04:01PM	NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time (NewMediaWire)
Mar-09-26 08:30AM	NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update (NewMediaWire) -6.43%
Mar-05-26 09:00AM	Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments (PR Newswire) +5.38%
Mar-03-26 08:30AM	NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares (NewMediaWire) +21.44%
Feb-26-26 08:29AM	NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time (NewMediaWire)
Feb-17-26 04:01PM	NeuroOne Medical Technologies Corp (NMTC) Q1 2026 Earnings Call Highlights: Navigating Revenue ... (GuruFocus.com) -16.50%
07:30AM	NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026 (NewMediaWire)
Feb-16-26 07:21AM	NeuroOne Medical Technologies Corp (NMTC) Q1 2026: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-04-26 04:01PM	NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time (NewMediaWire) -6.69% -8.38%
Jan-06-26 10:00AM	Best Momentum Stocks to Buy for January 6th (Zacks) +15.50%
05:33AM	New Strong Buy Stocks for January 6th (Zacks)
Dec-22-25 07:30AM	NeuroOne(R) Appoints Jason Mills to the Board of Directors (NewMediaWire) +9.49%
Dec-18-25 08:00PM	NeuroOne Medical Technologies Corp (NMTC) Q4 2025 Earnings Call Highlights: Record Revenue ... (GuruFocus.com) +7.20%
Dec-17-25 07:30AM	NeuroOne Reports Strong Fourth Quarter Fiscal 2025 Financial Results With Product Revenue Growth of 907% to $2.7 Million and 55.8% Gross Margin & Total Revenue Growth of 163% to $9.1 Million for Fiscal Year 2025 (NewMediaWire) -5.49%
Dec-16-25 07:15AM	Earnings To Watch: NeuroOne Medical Technologies Corp (NMTC) Reports Q4 2025 Result (GuruFocus.com) +6.93%
Dec-11-25 04:00PM	NeuroOne(R) to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Wednesday, December 17th at 8:30 a.m. Eastern Time (NewMediaWire) +12.38%
Dec-09-25 08:30AM	NeuroOne(R) Announces Initial Successful Cases Completed With OneRF(R) Trigeminal Nerve Ablation System at the University Hospitals in Cleveland (NewMediaWire)
Nov-19-25 08:30AM	NeuroOne(R) Announces Upcoming Industry Conference Participation (NewMediaWire)
Nov-05-25 08:30AM	NeuroOne(R) Receives 180-Day Extension From Nasdaq to Regain Minimum Bid Price Compliance (NewMediaWire)
Oct-16-25 09:31AM	NeuroOne Promotes Emily Johns to Chief Administrative Officer (NewMediaWire)
Oct-14-25 08:30AM	NeuroOne(R) Bolsters Patent Portfolio With Recent Decisions From Both the U.S. Patent & Trademark Office and European Patent Office (NewMediaWire)
Oct-06-25 04:10PM	NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST (NewMediaWire) +7.05% +6.47%
Sep-29-25 04:00PM	NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST (NewMediaWire)
Sep-08-25 04:05PM	NeuroOne to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025 (GlobeNewswire) +7.23% +5.12%
Aug-20-25 07:12AM	NeuroOne gains FDA clearance for trigeminal nerve ablation (MedTech Dive) -6.98%
Aug-19-25 10:13AM	NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment (Zacks)
05:38AM	NeuroOnes nerve ablation system secures FDA clearance (Medical Device Network)
Aug-18-25 08:30AM	NeuroOne Receives FDA 510(k) Clearance for OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire)
Aug-14-25 07:30AM	NeuroOne Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9% (GlobeNewswire)
Jul-31-25 12:12PM	NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update (GlobeNewswire)
08:30AM	NeuroOne to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time (GlobeNewswire)
Jul-23-25 08:30AM	NeuroOne Receives Notice of Allowance for Key Patent from U.S. Patent & Trademark Office (GlobeNewswire) -12.78%
Jun-23-25 08:30AM	NeuroOne Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF Ablation System (GlobeNewswire)
Jun-03-25 08:30AM	NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary (GlobeNewswire) -5.99%
May-29-25 01:05PM	NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025 (GlobeNewswire)
May-13-25 07:30AM	NeuroOne Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% (GlobeNewswire)
May-12-25 08:30AM	NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor (GlobeNewswire)
May-05-25 04:01PM	NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference (Newsfile)
May-01-25 09:55AM	NeuroOne to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time (GlobeNewswire)
Apr-23-25 09:00AM	NeuroOne Completes FDA Submission for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire) +9.45%
Apr-16-25 09:00AM	NeuroOne Issues Letter to Shareholders (GlobeNewswire)
Apr-14-25 09:00AM	NeuroOne OneRF Technology Success Story Featured on Fox News (GlobeNewswire) +17.49%
Apr-04-25 08:30AM	NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock (GlobeNewswire) -44.77%
Apr-03-25 04:05PM	NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Mar-18-25 01:12PM	NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace - Update (GlobeNewswire) -6.48%
09:00AM	NeuroOne CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today's Marketplace (GlobeNewswire)
08:46AM	NeuroOne CEO Joins Todays Marketplace To Discuss The Latest Treatments for Epilepsy (GlobeNewswire)
Mar-11-25 09:00AM	NeuroOne Accelerates Timeline of 510(k) Submission to FDA for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain (GlobeNewswire)
Mar-05-25 09:00AM	NeuroOne to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference (GlobeNewswire)
Feb-12-25 08:00AM	NeuroOne Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update (GlobeNewswire)
Feb-05-25 11:00AM	NeuroOne to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time (GlobeNewswire)
Feb-04-25 10:56AM	NeuroOne Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire) -10.11%
Jan-11-25 09:30AM	NeuroOne Reports Record Revenue Boost in Q1 2025 (TipRanks)
Jan-10-25 08:30AM	NeuroOne Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million (GlobeNewswire)
Jan-06-25 08:30AM	NeuroOne Announces Change of Virtual Investor Webinar to Friday, January 10, 2024 (GlobeNewswire) +13.04%
Jan-03-25 08:30AM	NeuroOne Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST (GlobeNewswire) +11.54%
Dec-17-24 08:30AM	NeuroOne Product Revenue Increases 77% to $3.5 Million in Fiscal 2024: Expects Product Revenue to Increase at Least 132% to at Least $8 Million in Fiscal 2025 (GlobeNewswire)
Dec-04-24 08:30AM	NeuroOne to Report Fourth Quarter and Fiscal Year 2024 Financial Results on December 17 at 9:00 a.m. Eastern Time (GlobeNewswire)
Dec-03-24 03:45PM	Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing (ACCESS Newswire)
Nov-13-24 09:30AM	NeuroOne Medical Technologies Corporation to Present at November 21st Virtual Investor Summit Microcap Event (ACCESSWIRE)
Oct-31-24 04:01PM	NeuroOne Announces Expansion of Existing Distribution Agreement with Zimmer Biomet for Commercialization of OneRF Ablation System (GlobeNewswire)
Oct-24-24 09:00AM	NeuroOne Medical Technologies to Present at the 2024 ThinkEquity Conference (GlobeNewswire) +5.26%
Sep-24-24 09:30AM	NeuroOne Spinal Cord Stimulation Electrode Technology to be Featured at The Business of Pain Conference (GlobeNewswire) +5.40%
Sep-10-24 09:00AM	NeuroOne Announces Breakthrough Case Completed with OneRF Ablation System at the University Hospitals in Cleveland (GlobeNewswire) +11.13%
Sep-05-24 06:23PM	NeuroOne to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-14-24 04:00PM	NeuroOne Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-12-24 11:30AM	NeuroOne to Report Third Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on August 14 (GlobeNewswire)
Aug-05-24 09:00AM	NeuroOne Announces $2.65 Million Equity Financing And $3.0 Million Credit Facility (GlobeNewswire) +7.25%
Jun-25-24 09:00AM	NeuroOne Announces First in Human Ablations Completed with OneRF Ablation System (GlobeNewswire) -19.08%
Jun-20-24 09:30AM	NeuroOne Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation (GlobeNewswire)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wambeke David J.	Chief Business Officer	Aug 27 '26	Buy	2.01	33,333	66,999	199,999	Sep 08 08:31 AM
Christianson Mark	Market Development Director	Jun 30 '26	Sale	3.18	10,000	31,773	20,692	Jul 02 04:39 PM
Christianson Mark	Officer	Jun 30 '26	Proposed Sale	3.34	10,000	33,400		Jun 30 09:02 AM
Christianson Mark	Business Development Director	Mar 30 '26	Sale	0.74	15,363	11,369	198,920	Apr 01 04:11 PM
Christianson Mark	Business Development Director	Mar 12 '26	Sale	0.80	817	654	214,383	Mar 16 03:30 PM
Christianson Mark	Business Development Director	Mar 13 '26	Sale	0.80	100	80	214,283	Mar 16 03:30 PM
Christianson Mark	Business Development Director	Mar 10 '26	Sale	0.80	11,611	9,289	217,309	Mar 12 03:58 PM
Christianson Mark	Business Development Director	Mar 11 '26	Sale	0.80	2,109	1,687	215,200	Mar 12 03:58 PM
Christianson Mark	Officer	Mar 09 '26	Proposed Sale	0.84	30,000	25,200		Mar 09 02:57 PM
Wambeke David J.	Chief Business Officer	Mar 01 '26	Buy	0.67	1,000,000	670,400	1,000,000	Mar 03 08:49 AM

NeuroOne Medical Technologies Corp. is a medical technology company, which engages in diagnostics, ablations, and deep brain stimulation technology for brain-related conditions. Its products include Evo Cortical, Evo sEEG, and OneRF. The company was founded by Mark Christianson on August 20, 2009 and is headquartered in Eden Prairie, MN.

PresidentMr. David A. Rosa M.D.

Chief Financial OfficerMr. Christopher R. Volker CFA

Senior AdvisorMr. Ronald W. McClurg

Co-FounderMr. Mark Christianson

Chief Technology OfficerMr. Steven Mertens

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NMTC

NeuroOne Medical Technologies Corp

Upgrade your Finviz experience